Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BIO-TECHNE (TECH) Total Current Liabilities: 2010-2025

Historic Total Current Liabilities for BIO-TECHNE (TECH) over the last 16 years, with Sep 2025 value amounting to $144.5 million.

  • BIO-TECHNE's Total Current Liabilities rose 1.70% to $144.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $144.5 million, marking a year-over-year increase of 1.70%. This contributed to the annual value of $175.8 million for FY2025, which is 10.33% up from last year.
  • BIO-TECHNE's Total Current Liabilities amounted to $144.5 million in Q3 2025, which was down 17.80% from $175.8 million recorded in Q2 2025.
  • BIO-TECHNE's 5-year Total Current Liabilities high stood at $176.0 million for Q2 2022, and its period low was $127.8 million during Q3 2023.
  • Moreover, its 3-year median value for Total Current Liabilities was $144.5 million (2025), whereas its average is $148.6 million.
  • Per our database at Business Quant, BIO-TECHNE's Total Current Liabilities surged by 42.76% in 2021 and then declined by 26.99% in 2023.
  • Quarterly analysis of 5 years shows BIO-TECHNE's Total Current Liabilities stood at $154.8 million in 2021, then dropped by 17.06% to $128.4 million in 2022, then increased by 5.32% to $135.2 million in 2023, then increased by 19.24% to $161.3 million in 2024, then increased by 1.70% to $144.5 million in 2025.
  • Its Total Current Liabilities stands at $144.5 million for Q3 2025, versus $175.8 million for Q2 2025 and $169.2 million for Q1 2025.